← Open Payments lookup

KAYLEIGH KING: Open Payments

NPI 1821219114 · IRVING, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,737 in 95 payments from 31 companies in 2025. Trend: 2023 $247 · 2024 $3,024 · 2025 $2,737

Food & beverage: $2,039Long term medical supply or device loan: $598Education: $100
CompanyPaymentsAmount
Novartis Pharmaceuticals Corporation9$676
Daiichi Sankyo Inc.4$189
Incyte Corporation7$183
Janssen Biotech, Inc.8$182
Celgene Corporation7$150
ABBVIE INC.7$142
AstraZeneca Pharmaceuticals LP6$132
Merck Sharp & Dohme LLC5$116
Lilly USA, LLC4$96
Abbott Laboratories4$93

Products named: KISQALI, Enhertu, REBLOZYL, KEYTRUDA, VERZENIO, FREESTYLE LIBRE 3, AYVAKIT, VENCLEXTA.

Industry payments across TX — which companies pay providers there.